Novartis’ Foradil Should Add “Black Box” Warning About Potential Class Effect In Asthmatics
This article was originally published in The Pink Sheet Daily
Executive Summary
Boxed warning should explain that increases in asthma-related deaths have been seen in studies of related agent salmeterol (GSK’s Serevent and Advair) and the risk could extend to Foradil (formoterol), advisory committee says. Continued marketing of Serevent, Advair and Foradil supported by the panel.